Corbus Pharmaceuticals completes enrollment in obesity drug trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. MSTR
4. BAUFF
5. ICE
6. ABBV
7. DFTX
8. BTGO
9. FCLI
10. CART

Go back to Corbus Pharmaceuticals completes enrollment in obesity drug trial
(NASDAQ: CRBP) Delayed: 8.26 --0 (-0%)
Previous Close $8.26    52 Week High $10.78 
Open $8.26    52 Week Low $1.01 
Day High $8.26    P/E N/A 
Day Low $8.26    EPS $0.00 
Volume 1,505